Abstract Title:

Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells.

Abstract Source:

Leuk Lymphoma. 2009 Apr;50(4):625-32. PMID: 19373661

Abstract Author(s):

Rami Hayun, Eitan Okun, Alain Berrebi, Lev Shvidel, Lucette Bassous, Benjamin Sredni, Uri Nir

Article Affiliation:

The Mina and Everard Goodman Faculty of Life Sciences, Safdie Institute for AIDS and Immunology Research, Bar-Ilan University, Ramat-Gan, Israel.

Abstract:

B chronic lymphocytic leukemia (B-CLL) cells exist in patients as slowly accumulating resting as well as proliferating B cells. In this study, we examined whether Rapamycin and Curcumin, two naturally occurring compounds shown to have apoptotic effects, could selectively induce apoptosis in resting B-CLL cells. Mononuclear cells isolated from patients with B-CLL were treated with these agents and analysed by AnnexinV/propidium iodide binding, caspase activity, and changes in bcl-2/Bax ratio. Rapamycin and curcumin significantly induced apoptosis in resting B-CLL cells obtained from patients with CLL. Furthermore, rapamycin and curcumin increased caspase 9, 3 and 7 activity, decreased anti-apoptotic bcl-2 levels, and increased the pro-apoptotic protein Bax. These data suggest rapamycin and curcumin may be an effective treatment for B-CLL and are of high clinical significance considering the growing population of patients and lack of efficient treatment for this malignant disease.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.